Gentian Diagnostics ASA — M&A Activity 2023

Jun 15, 2023

Gentian acquires Getica for SEK 3.0 million

Gentian acquires Getica for SEK 3.0 million

Moss, 15 June 2023

Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests, is pleased to announce that it has entered into an agreement to acquire Getica AB from Erling Sundrehagen. Getica AB, located in Gothenburg Sweden, is currently offering antibody purification services exclusively to Gentian Diagnostics and is also a provider of diagnostics research & development services. The company currently has five employees.

With this acquisition, Gentian Diagnostics will secure critical production competence in an essential step in the manufacturing process and realize operational gains estimated to be approximately NOK 2.0 million from 2024. In addition, Gentian Diagnostics will gain access to unique R&D capabilities.

Under the agreement, Gentian Diagnostics will pay a cash consideration of SEK 3.0 million for Getica AB and closing is expected to take place in early July.

IR contact:

Njaal Kind, CFO and COO

njaal.kind@gentian.no

+47 919 06 525 (mobile)